欧洲过敏和临床免疫学会免疫球蛋白E介导食物过敏管理指南解读  

Interpretation of European Academy of Allergy and Clinical Immunology guidelines on the management of immunoglobulin E-mediated food allergy

作　　者：韩鹏申 昆玲 Han Peng;Shen Kunling(Department of Respiratory Diseases,Shenzhen Children′s Hospital,Shenzhen 518038,China;Department of Respiratory,Beijing Children′s Hospital,Capital Medical University,China National Clinical Research Center of Respiratory Diseases,National Center for Children′s Health,Beijing 100045,China)

机构地区：[1]深圳市儿童医院呼吸科,深圳518038 [2]国家儿童医学中心,国家呼吸系统疾病临床医学研究中心,首都医科大学附属北京儿童医院呼吸科,北京100045

出　　处：《中华实用儿科临床杂志》2025年第2期92-96,共5页Chinese Journal of Applied Clinical Pediatrics

基　　金：广东省高水平医院建设专项经费(粤府办2021-6)。

摘　　要：食物过敏是全球范围内最常见的慢性非感染性疾病之一,患病率呈上升趋势。欧洲过敏和临床免疫学会在2024年发表了免疫球蛋白E介导食物过敏管理指南。该指南采用建议、评估、发展和评价分级评价体系,围绕饮食干预、心理支持、管理计划、过敏原特异性免疫治疗和生物制剂5个方面提出14项建议。现从建议强度、推荐原因和实际意义出发对该指南进行解读,以期为临床工作提供参考,提高食物过敏的管理水平。Food allergy is one of the most prevalent chronic non-infectious diseases globally,with an increasing incidence.In 2024,the European Academy of Allergy and Clinical Immunology published guidelines on the management of immunoglobulin E-mediated food allergy.The guidelines employ the Grading of Recommendations Assessment,Development,and Evaluation evaluation system and put forth 14 recommendations pertaining to 5 key areas:dietary intervention,psychological support,management plans,allergen-specific immunotherapy,and biological agents.This article interprets the guidelines from the perspective of strength,reasons,and practical significance.The aim is to provide a reference for clinical work and to improve the level of management of food allergies.

关 键 词：食物过敏 严重过敏反应 饮食 生物制剂 过敏原免疫治疗 

分 类 号：R593.1[医药卫生—内科学]